Literature DB >> 22427507

Effects of a stepped-care intervention programme among older subjects who screened positive for depressive symptoms in general practice: the PROMODE randomised controlled trial.

Gerda M van der Weele1, Margot W M de Waal, Wilbert B van den Hout, Anton J M de Craen, Philip Spinhoven, Theo Stijnen, Willem J J Assendelft, Roos C van der Mast, Jacobijn Gussekloo.   

Abstract

OBJECTIVES: to determine (cost)-effectiveness of a stepped-care intervention programme among subjects ≥ 75 years who screened positive for depressive symptoms in general practice.
DESIGN: the pragmatic cluster-randomised controlled trial with 12-month follow-up.
SETTING: sixty-seven Dutch general practices.
SUBJECTS: two hundred and thirty-nine subjects ≥ 75 years screened positive for untreated depressive symptoms (15-item Geriatric Depression Scale ≥ 5).
METHODS: usual care (34 practices, 118 subjects) was compared with the stepped-care intervention (33 practices, 121 subjects) consisting of three steps: individual counselling; Coping with Depression course; and-if indicated-referral back to general practitioner to discuss further treatment. Measurements included severity of depressive symptoms [Montgomery-Åsberg Depression Rating Scale (MADRS)], quality of life, mortality and costs.
RESULTS: at baseline subjects mostly were mildly/moderately depressed. At 6 months MADRS scores had improved more in the usual care than the intervention group (-2.9 versus -1.1 points, P=0.032), but not at 12 months (-3.1 versus -4.6, P=0.084). No significant differences were found within two separate age groups (75-79 years and ≥ 80 years). In intervention practices, 83% accepted referral to the stepped-care programme, and 19% accepted course participation. The control group appeared to have received more psychological care.
CONCLUSIONS: among older subjects who screened positive for depressive symptoms, an offered stepped-care intervention programme was not (cost)-effective compared with usual care, possibly due to a low uptake of the course offer. TRIAL REGISTRATION: www.controlled-trials.com/ISRCTN 71142851v.

Entities:  

Mesh:

Year:  2012        PMID: 22427507     DOI: 10.1093/ageing/afs027

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  11 in total

1.  Step one within stepped care trauma-focused cognitive behavioral therapy for young children: a pilot study.

Authors:  Alison Salloum; John Robst; Michael S Scheeringa; Judith A Cohen; Wei Wang; Tanya K Murphy; David F Tolin; Eric A Storch
Journal:  Child Psychiatry Hum Dev       Date:  2014-02

Review 2.  Cost-effectiveness of collaborative care for the treatment of depressive disorders in primary care: a systematic review.

Authors:  Thomas Grochtdreis; Christian Brettschneider; Annemarie Wegener; Birgit Watzke; Steffi Riedel-Heller; Martin Härter; Hans-Helmut König
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

3.  Consistency and sources of divergence in recommendations on screening with questionnaires for presently experienced health problems or symptoms: a comparison of recommendations from the Canadian Task Force on Preventive Health Care, UK National Screening Committee, and US Preventive Services Task Force.

Authors:  Brett D Thombs; Nazanin Saadat; Kira E Riehm; Justin Michael Karter; Akansha Vaswani; Bonnie K Andrews; Peter Simons; Lisa Cosgrove
Journal:  BMC Med       Date:  2017-08-09       Impact factor: 8.775

4.  Favourable outcomes of a preventive screening and counselling programme for older people in underprivileged areas in the Netherlands: The PRIMUS project.

Authors:  D J Annemarie van Dijk; Matty R Crone; Pepijn van Empelen; Willem J Assendelft; Barend J Middelkoop
Journal:  Prev Med Rep       Date:  2017-03-22

5.  Process evaluation of a stepped-care program to prevent depression in primary care: patients' and practice nurses' experiences.

Authors:  Alide D Pols; Karen Schipper; Debbie Overkamp; Susan E van Dijk; Judith E Bosmans; Harm W J van Marwijk; Marcel C Adriaanse; Maurits W van Tulder
Journal:  BMC Fam Pract       Date:  2017-02-23       Impact factor: 2.497

6.  Patients' and practice nurses' perceptions of depression in patients with type 2 diabetes and/or coronary heart disease screened for subthreshold depression.

Authors:  Alide D Pols; Karen Schipper; Debbie Overkamp; Harm W J van Marwijk; Maurits W van Tulder; Marcel C Adriaanse
Journal:  BMC Fam Pract       Date:  2018-12-23       Impact factor: 2.497

7.  Effectiveness and cost-effectiveness of a proactive, goal-oriented, integrated care model in general practice for older people. A cluster randomised controlled trial: Integrated Systematic Care for older People--the ISCOPE study.

Authors:  Jeanet Blom; Wendy den Elzen; Anne H van Houwelingen; Margot Heijmans; Theo Stijnen; Wilbert Van den Hout; Jacobijn Gussekloo
Journal:  Age Ageing       Date:  2016-01       Impact factor: 10.668

8.  Effectiveness of a stepped-care intervention to prevent major depression in patients with type 2 diabetes mellitus and/or coronary heart disease and subthreshold depression: A pragmatic cluster randomized controlled trial.

Authors:  Alide D Pols; Susan E van Dijk; Judith E Bosmans; Trynke Hoekstra; Harm W J van Marwijk; Maurits W van Tulder; Marcel C Adriaanse
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240

9.  Effectiveness of a multifactorial intervention for dizziness in older people in primary care: A cluster randomised controlled trial.

Authors:  Hanneke Stam; Johannes C van der Wouden; Jacqueline G Hugtenburg; Jos W R Twisk; Henriëtte E van der Horst; Otto R Maarsingh
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

10.  An Internet-based Acceptance and Commitment Therapy intervention for older adults with anxiety complaints: study protocol for a cluster randomized controlled trial.

Authors:  Maartje Witlox; Vivivan Kraaij; Nadia Garnefski; Margot W M de Waal; Filip Smit; Erik Hoencamp; Jacobijn Gussekloo; Ernst T Bohlmeijer; Philip Spinhoven
Journal:  Trials       Date:  2018-09-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.